Abstract
A 32 year old woman presented with a syncopal attack and dyspnoea on exertion. A diagnosis of primary pulmonary hypertension was confirmed by clinical examination, cardiac catheterisation, and pulmonary angiography. Her symptoms resolved completely with oral diazoxide and the pulmonary arterial pressure was reduced to normal levels over a period of six years. When diazoxide was discontinued on two separate occasions pulmonary hypertension recurred. This demonstrated the continued presence of the underlying stimulus for vasoconstriction.
Full text
PDFSelected References
These references are in PubMed. This may not be the complete list of references from this article.
- Bourdillon P. D., Oakley C. M. Regression of primary pulmonary hypertension. Br Heart J. 1976 Mar;38(3):264–270. doi: 10.1136/hrt.38.3.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Buch J., Wennevold A. Hazards of diazoxide in pulmonary hypertension. Br Heart J. 1981 Oct;46(4):401–403. doi: 10.1136/hrt.46.4.401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Camerini F., Alberti E., Klugmann S., Salvi A. Primary pulmonary hypertension: effects of nifedipine. Br Heart J. 1980 Sep;44(3):352–356. doi: 10.1136/hrt.44.3.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Edwards W. D., Edwards J. E. Clinical primary pulmonary hypertension: three pathologic types. Circulation. 1977 Nov;56(5):884–888. doi: 10.1161/01.cir.56.5.884. [DOI] [PubMed] [Google Scholar]
- Fujii A., Rabinovitch M., Matthews E. C. A case of spontaneous resolution of idiopathic pulmonary hypertension. Br Heart J. 1981 Nov;46(5):574–577. doi: 10.1136/hrt.46.5.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Fuster V., Steele P. M., Edwards W. D., Gersh B. J., McGoon M. D., Frye R. L. Primary pulmonary hypertension: natural history and the importance of thrombosis. Circulation. 1984 Oct;70(4):580–587. doi: 10.1161/01.cir.70.4.580. [DOI] [PubMed] [Google Scholar]
- Hall D. R. Remission of primary pulmonary hypertension during treatment with diazoxide. Br Med J (Clin Res Ed) 1981 Apr 4;282(6270):1118–1118. doi: 10.1136/bmj.282.6270.1118. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klinke W. P., Gilbert J. A. Diazoxide in primary pulmonary hypertension. N Engl J Med. 1980 Jan 10;302(2):91–92. doi: 10.1056/NEJM198001103020204. [DOI] [PubMed] [Google Scholar]
- Malcić I., Richter D. Verapamil in primary pulmonary hypertension. Br Heart J. 1985 Mar;53(3):345–347. doi: 10.1136/hrt.53.3.345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Pietro D. A., LaBresh K. A., Shulman R. M., Folland E. D., Parisi A. F., Sasahara A. A. Sustained improvement in primary pulmonary hypertension during six years of treatment with sublingual isoproterenol. N Engl J Med. 1984 Apr 19;310(16):1032–1034. doi: 10.1056/NEJM198404193101606. [DOI] [PubMed] [Google Scholar]
- Rubino J. M., Schroeder J. S. Diazoxide in treatment of primary pulmonary hypertension. Br Heart J. 1979 Sep;42(3):362–363. doi: 10.1136/hrt.42.3.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SAMET P., BERNSTEIN W. H., WIDRICH J. Intracardiac infusion of acetylcholine in primary pulmonary hypertension. Am Heart J. 1960 Sep;60:433–439. doi: 10.1016/0002-8703(60)90202-7. [DOI] [PubMed] [Google Scholar]
- Shettigar U. R., Hultgren H. N., Specter M., Martin R., Davies D. H. Primary pulmonary hypertension favorable effect of isoproterenol. N Engl J Med. 1976 Dec 16;295(25):1414–1415. doi: 10.1056/NEJM197612162952506. [DOI] [PubMed] [Google Scholar]
- WOOD P. Pulmonary hypertension with special reference to the vasoconstrictive factor. Br Heart J. 1958 Oct;20(4):557–570. doi: 10.1136/hrt.20.4.557. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wang S. W., Pohl J. E., Rowlands D. J., Wade E. G. Diazoxide in treatment of primary pulmonary hypertension. Br Heart J. 1978 May;40(5):572–574. doi: 10.1136/hrt.40.5.572. [DOI] [PMC free article] [PubMed] [Google Scholar]